Non Small Cell Lung Cancer — Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759
Citation(s)
A Phase I/II, Open-label, Multi-center Study to Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 in Chinese Patients With EGFRm+ NSCLC With Central Nervous System (CNS) Metastases